Figure 1.

Cumulative incidence curves of transplant-related mortality (A) and relapse or progression (B) of 37 patients with advanced primary cutaneous T-cell lymphoma after allogeneic HSCT. (A) Incidence of transplant-related mortality in 37 patients with advanced primary cutaneous T-cell lymphoma, according to the use of T-cell depletion, yes versus no. (B) Incidence of relapse or progression in 37 patients with advanced primary cutaneous T-cell lymphoma, including 20 patients with transformed mycosis fungoides